nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.0335	0.0674	CcSEcCtD
Lovastatin—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.021	0.0422	CcSEcCtD
Lovastatin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.02	0.0402	CcSEcCtD
Lovastatin—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0155	0.0313	CcSEcCtD
Lovastatin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.0144	0.0291	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0277	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0231	CcSEcCtD
Lovastatin—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0114	0.023	CcSEcCtD
Lovastatin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0229	CcSEcCtD
Lovastatin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0225	CcSEcCtD
Lovastatin—Injury—Riluzole—amyotrophic lateral sclerosis	0.0109	0.0218	CcSEcCtD
Lovastatin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0214	CcSEcCtD
Lovastatin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0208	CcSEcCtD
Lovastatin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0207	CcSEcCtD
Lovastatin—HDAC2—tongue—amyotrophic lateral sclerosis	0.0096	0.0967	CbGeAlD
Lovastatin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00863	0.0174	CcSEcCtD
Lovastatin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00846	0.017	CcSEcCtD
Lovastatin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00827	0.0166	CcSEcCtD
Lovastatin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00795	0.016	CcSEcCtD
Lovastatin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00788	0.0158	CcSEcCtD
Lovastatin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0152	CcSEcCtD
Lovastatin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00748	0.015	CcSEcCtD
Lovastatin—HDAC2—hindbrain—amyotrophic lateral sclerosis	0.00736	0.0741	CbGeAlD
Lovastatin—ITGAL—medulla oblongata—amyotrophic lateral sclerosis	0.00736	0.0741	CbGeAlD
Lovastatin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00722	0.0145	CcSEcCtD
Lovastatin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00691	0.0139	CcSEcCtD
Lovastatin—ITGAL—spinal cord—amyotrophic lateral sclerosis	0.00656	0.0661	CbGeAlD
Lovastatin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0131	CcSEcCtD
Lovastatin—Chills—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0125	CcSEcCtD
Lovastatin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0061	0.0123	CcSEcCtD
Lovastatin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00592	0.0119	CcSEcCtD
Lovastatin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00589	0.0118	CcSEcCtD
Lovastatin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00582	0.0117	CcSEcCtD
Lovastatin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00578	0.0116	CcSEcCtD
Lovastatin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00563	0.0113	CcSEcCtD
Lovastatin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00558	0.0112	CcSEcCtD
Lovastatin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00549	0.0111	CcSEcCtD
Lovastatin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0109	CcSEcCtD
Lovastatin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0054	0.0109	CcSEcCtD
Lovastatin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00538	0.0108	CcSEcCtD
Lovastatin—ITGAL—cerebellum—amyotrophic lateral sclerosis	0.0052	0.0524	CbGeAlD
Lovastatin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0103	CcSEcCtD
Lovastatin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0103	CcSEcCtD
Lovastatin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00512	0.0103	CcSEcCtD
Lovastatin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0051	0.0103	CcSEcCtD
Lovastatin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0102	CcSEcCtD
Lovastatin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00501	0.0101	CcSEcCtD
Lovastatin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00495	0.00995	CcSEcCtD
Lovastatin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00491	0.00987	CcSEcCtD
Lovastatin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00487	0.00981	CcSEcCtD
Lovastatin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0048	0.00966	CcSEcCtD
Lovastatin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00941	CcSEcCtD
Lovastatin—HDAC2—embryo—amyotrophic lateral sclerosis	0.0046	0.0463	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00899	CcSEcCtD
Lovastatin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00444	0.00893	CcSEcCtD
Lovastatin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00886	CcSEcCtD
Lovastatin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00437	0.0088	CcSEcCtD
Lovastatin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00869	CcSEcCtD
Lovastatin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00858	CcSEcCtD
Lovastatin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00423	0.00851	CcSEcCtD
Lovastatin—ITGAL—brain—amyotrophic lateral sclerosis	0.00422	0.0426	CbGeAlD
Lovastatin—HDAC2—brainstem—amyotrophic lateral sclerosis	0.00422	0.0425	CbGeAlD
Lovastatin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00844	CcSEcCtD
Lovastatin—Pain—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00844	CcSEcCtD
Lovastatin—PON3—brain—amyotrophic lateral sclerosis	0.00414	0.0417	CbGeAlD
Lovastatin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00404	0.00813	CcSEcCtD
Lovastatin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00807	CcSEcCtD
Lovastatin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00784	CcSEcCtD
Lovastatin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00388	0.0078	CcSEcCtD
Lovastatin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00388	0.0078	CcSEcCtD
Lovastatin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00362	0.00727	CcSEcCtD
Lovastatin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00708	CcSEcCtD
Lovastatin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00698	CcSEcCtD
Lovastatin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00675	CcSEcCtD
Lovastatin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00653	CcSEcCtD
Lovastatin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00628	CcSEcCtD
Lovastatin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00622	CcSEcCtD
Lovastatin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00622	CcSEcCtD
Lovastatin—Headache—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00618	CcSEcCtD
Lovastatin—HDAC2—medulla oblongata—amyotrophic lateral sclerosis	0.00294	0.0296	CbGeAlD
Lovastatin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00586	CcSEcCtD
Lovastatin—HMGCR—medulla oblongata—amyotrophic lateral sclerosis	0.00265	0.0267	CbGeAlD
Lovastatin—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00241	0.0243	CbGeAlD
Lovastatin—HMGCR—spinal cord—amyotrophic lateral sclerosis	0.00237	0.0238	CbGeAlD
Lovastatin—HDAC2—nervous system—amyotrophic lateral sclerosis	0.00221	0.0223	CbGeAlD
Lovastatin—HDAC2—central nervous system—amyotrophic lateral sclerosis	0.00213	0.0214	CbGeAlD
Lovastatin—HDAC2—cerebellum—amyotrophic lateral sclerosis	0.00208	0.0209	CbGeAlD
Lovastatin—SLCO1A2—medulla oblongata—amyotrophic lateral sclerosis	0.00207	0.0208	CbGeAlD
Lovastatin—HMGCR—nervous system—amyotrophic lateral sclerosis	0.00199	0.0201	CbGeAlD
Lovastatin—HMGCR—central nervous system—amyotrophic lateral sclerosis	0.00192	0.0193	CbGeAlD
Lovastatin—HMGCR—cerebellum—amyotrophic lateral sclerosis	0.00188	0.0189	CbGeAlD
Lovastatin—SLCO1A2—spinal cord—amyotrophic lateral sclerosis	0.00184	0.0186	CbGeAlD
Lovastatin—HDAC2—brain—amyotrophic lateral sclerosis	0.00169	0.017	CbGeAlD
Lovastatin—SLCO1A2—nervous system—amyotrophic lateral sclerosis	0.00155	0.0157	CbGeAlD
Lovastatin—HMGCR—brain—amyotrophic lateral sclerosis	0.00152	0.0153	CbGeAlD
Lovastatin—SLCO1A2—central nervous system—amyotrophic lateral sclerosis	0.0015	0.0151	CbGeAlD
Lovastatin—SLCO1A2—cerebellum—amyotrophic lateral sclerosis	0.00146	0.0147	CbGeAlD
Lovastatin—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00138	0.0139	CbGeAlD
Lovastatin—SLCO1A2—brain—amyotrophic lateral sclerosis	0.00119	0.012	CbGeAlD
Lovastatin—ABCB1—embryo—amyotrophic lateral sclerosis	0.00108	0.0109	CbGeAlD
Lovastatin—CYP2C8—brain—amyotrophic lateral sclerosis	0.00083	0.00836	CbGeAlD
Lovastatin—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000735	0.00741	CbGeAlD
Lovastatin—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000724	0.00729	CbGeAlD
Lovastatin—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000708	0.00713	CbGeAlD
Lovastatin—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000697	0.00702	CbGeAlD
Lovastatin—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000693	0.00698	CbGeAlD
Lovastatin—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000681	0.00686	CbGeAlD
Lovastatin—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000618	0.00622	CbGeAlD
Lovastatin—CYP2D6—brain—amyotrophic lateral sclerosis	0.000553	0.00557	CbGeAlD
Lovastatin—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000521	0.00524	CbGeAlD
Lovastatin—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000501	0.00505	CbGeAlD
Lovastatin—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.00049	0.00493	CbGeAlD
Lovastatin—ABCB1—brain—amyotrophic lateral sclerosis	0.000398	0.00401	CbGeAlD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000342	0.000848	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000341	0.000845	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00034	0.000842	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00034	0.000842	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000339	0.000839	CbGpPWpGaD
Lovastatin—HDAC2—Disease—VCP—amyotrophic lateral sclerosis	0.000334	0.000829	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000333	0.000825	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—TP53—amyotrophic lateral sclerosis	0.000332	0.000824	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000331	0.000819	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00033	0.000818	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000329	0.000815	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000328	0.000813	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000328	0.000813	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000323	0.000801	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000323	0.0008	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000321	0.000794	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00032	0.000794	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00032	0.000794	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000317	0.000785	CbGpPWpGaD
Lovastatin—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000316	0.000783	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000315	0.00078	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000315	0.000779	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000313	0.000776	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000312	0.000772	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000311	0.00077	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000311	0.00077	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.0003	0.000743	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000298	0.000738	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000296	0.000733	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000296	0.000733	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000293	0.000725	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000292	0.000724	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00029	0.000719	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000289	0.000716	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—amyotrophic lateral sclerosis	0.000278	0.00069	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000278	0.000688	CbGpPWpGaD
Lovastatin—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000274	0.000678	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000272	0.000675	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—amyotrophic lateral sclerosis	0.000272	0.000674	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000272	0.000673	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000272	0.000673	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000268	0.000663	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000263	0.000651	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000262	0.000649	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000254	0.000629	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000251	0.000623	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000248	0.000614	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000247	0.000612	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000246	0.000609	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000246	0.000609	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000246	0.000609	CbGpPWpGaD
Lovastatin—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000244	0.000606	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000243	0.000602	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CST3—amyotrophic lateral sclerosis	0.00024	0.000595	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.00024	0.000594	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000237	0.000588	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000234	0.00058	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000234	0.000579	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000228	0.000565	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000227	0.000562	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000226	0.00056	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000225	0.000557	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000225	0.000557	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000223	0.000552	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000221	0.000548	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000219	0.000542	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000217	0.000537	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000214	0.00053	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000213	0.000528	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000213	0.000527	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000213	0.000527	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000212	0.000526	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000209	0.000517	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000206	0.000512	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000204	0.000506	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000204	0.000506	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000204	0.000505	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000203	0.000503	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000201	0.000499	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000199	0.000494	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000199	0.000493	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000198	0.000491	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000197	0.000489	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000196	0.000487	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000195	0.000482	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000193	0.000479	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00019	0.00047	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00019	0.00047	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000187	0.000464	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000186	0.000461	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000186	0.000461	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000185	0.000459	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000185	0.000459	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000184	0.000456	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000181	0.000448	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00018	0.000445	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000178	0.00044	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000177	0.000439	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000175	0.000433	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000175	0.000433	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CASP9—amyotrophic lateral sclerosis	0.000175	0.000432	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000174	0.00043	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000173	0.000429	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000173	0.000429	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000172	0.000426	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000171	0.000422	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00017	0.000421	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00017	0.00042	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000168	0.000416	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000164	0.000407	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000164	0.000407	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000164	0.000406	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000161	0.0004	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000161	0.0004	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00016	0.000397	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00016	0.000396	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000158	0.000392	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000158	0.00039	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000154	0.000381	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000154	0.000381	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000152	0.000376	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ERBB4—amyotrophic lateral sclerosis	0.000149	0.00037	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000149	0.000369	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000149	0.000368	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000148	0.000367	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000147	0.000365	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000147	0.000364	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000147	0.000364	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000146	0.000363	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000141	0.00035	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00014	0.000348	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00014	0.000346	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000139	0.000344	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000138	0.000343	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	0.000137	0.00034	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000137	0.000339	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000135	0.000333	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000134	0.000332	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000323	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000129	0.000319	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000128	0.000318	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000126	0.000313	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000125	0.00031	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000124	0.000308	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000122	0.000303	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—APOE—amyotrophic lateral sclerosis	0.000121	0.0003	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00012	0.000297	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000117	0.000289	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APOE—amyotrophic lateral sclerosis	0.000116	0.000286	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000115	0.000286	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000114	0.000283	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000114	0.000283	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000112	0.000278	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000111	0.000275	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000108	0.000267	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000107	0.000265	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000105	0.000259	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000104	0.000259	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000104	0.000258	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000102	0.000253	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000102	0.000253	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000102	0.000252	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	9.87e-05	0.000244	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.83e-05	0.000244	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.8e-05	0.000243	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—amyotrophic lateral sclerosis	9.73e-05	0.000241	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.71e-05	0.000241	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.66e-05	0.000239	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.61e-05	0.000238	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	9.6e-05	0.000238	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	9.57e-05	0.000237	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	9.49e-05	0.000235	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	9.37e-05	0.000232	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	9.13e-05	0.000226	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	9.08e-05	0.000225	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.02e-05	0.000223	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.88e-05	0.00022	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	8.84e-05	0.000219	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	8.83e-05	0.000219	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	8.76e-05	0.000217	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.75e-05	0.000217	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.69e-05	0.000215	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	8.39e-05	0.000208	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.29e-05	0.000205	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.29e-05	0.000205	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.26e-05	0.000205	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	8.26e-05	0.000205	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.09e-05	0.0002	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.06e-05	0.0002	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.97e-05	0.000198	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—amyotrophic lateral sclerosis	7.92e-05	0.000196	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	7.89e-05	0.000195	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.7e-05	0.000191	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.59e-05	0.000188	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.58e-05	0.000188	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOE—amyotrophic lateral sclerosis	7.31e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.25e-05	0.00018	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.2e-05	0.000178	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	7.19e-05	0.000178	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.97e-05	0.000173	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	6.86e-05	0.00017	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	6.82e-05	0.000169	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.76e-05	0.000168	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.69e-05	0.000166	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.56e-05	0.000163	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.26e-05	0.000155	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	6.25e-05	0.000155	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.77e-05	0.000143	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.75e-05	0.000142	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	5.73e-05	0.000142	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.52e-05	0.000137	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.48e-05	0.000136	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.15e-05	0.000128	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.04e-05	0.000125	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.01e-05	0.000124	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.93e-05	0.000122	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.86e-05	0.00012	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.75e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.74e-05	0.000117	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.67e-05	0.000116	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.5e-05	0.000111	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.37e-05	0.000108	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.36e-05	0.000108	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.28e-05	0.000106	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.24e-05	0.000105	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.15e-05	0.000103	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.14e-05	0.000102	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.93e-05	9.73e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.9e-05	9.66e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.89e-05	9.65e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.86e-05	9.57e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.8e-05	9.42e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.59e-05	8.89e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.58e-05	8.87e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.55e-05	8.8e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.3e-05	8.18e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.2e-05	7.94e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	3.13e-05	7.75e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.95e-05	7.3e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	2.92e-05	7.24e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.84e-05	7.04e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.55e-05	6.31e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.46e-05	6.09e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.34e-05	5.8e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.2e-05	5.44e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.14e-05	5.31e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.02e-05	5e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2e-05	4.96e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.93e-05	4.77e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.32e-05	3.27e-05	CbGpPWpGaD
